Edgewise Therapeutics, Inc.
US ˙ NasdaqGS ˙ US28036F1057

Introduction

This page provides a comprehensive analysis of the known insider trading history of John R Moore. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John R Moore has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EWTX / Edgewise Therapeutics, Inc. General Counsel 10,214
US:04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020 VP, General Counsel 40,102
US:NVLS / Nivalis Therapeutics, Inc. Director 12,300
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John R Moore. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EWTX / Edgewise Therapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EWTX / Edgewise Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EWTX / Edgewise Therapeutics, Inc. Insider Trades
Insider Sales EWTX / Edgewise Therapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EWTX / Edgewise Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-08-12 EWTX MOORE JOHN R 2,098 13.3924 2,098 13.3924 28,097 0 13.3900 -5 -0.02
2025-05-02 EWTX MOORE JOHN R 1,930 16.4542 1,930 16.4542 31,757
2024-09-23 EWTX MOORE JOHN R 20,922 27.6295 20,922 27.6295 578,064
2024-09-20 EWTX MOORE JOHN R 50,000 28.3702 50,000 28.3702 1,418,510
2024-05-02 EWTX MOORE JOHN R 1,956 18.9100 1,956 18.9100 36,988
2024-02-09 EWTX MOORE JOHN R 8,029 20.0096 8,029 20.0096 160,657
2024-02-08 EWTX MOORE JOHN R 3,813 20.0065 3,813 20.0065 76,285
2024-02-07 EWTX MOORE JOHN R 17,993 20.0002 17,993 20.0002 359,864
2023-05-02 EWTX MOORE JOHN R 1,897 8.9049 1,897 8.9049 16,893
2022-08-03 EWTX MOORE JOHN R 9,232 9.3069 9,232 9.3069 85,921
2022-07-06 EWTX MOORE JOHN R 1,046 8.5352 1,046 8.5352 8,928
2022-07-05 EWTX MOORE JOHN R 8,186 8.3470 8,186 8.3470 68,329
2022-06-21 EWTX MOORE JOHN R 31,078 7.2944 31,078 7.2944 226,695
2022-06-17 EWTX MOORE JOHN R 22,127 6.6179 22,127 6.6179 146,434
2022-06-16 EWTX MOORE JOHN R 14,722 6.1680 14,722 6.1680 90,805
2022-06-15 EWTX MOORE JOHN R 585 6.1104 585 6.1104 3,575
2022-06-15 EWTX MOORE JOHN R 18,075 6.1104 18,075 6.1104 110,445
2022-06-14 EWTX MOORE JOHN R 3,628 6.0239 3,628 6.0239 21,855
2022-06-13 EWTX MOORE JOHN R 4,093 6.0058 4,093 6.0058 24,582
2022-06-10 EWTX MOORE JOHN R 7,125 6.0519 7,125 6.0519 43,120
2022-06-09 EWTX MOORE JOHN R 7,615 6.4868 7,615 6.4868 49,397
2022-06-08 EWTX MOORE JOHN R 12,566 6.6339 12,566 6.6339 83,362
2022-06-07 EWTX MOORE JOHN R 973 6.6050 973 6.6050 6,427
2022-06-07 EWTX MOORE JOHN R 17,150 6.6050 17,150 6.6050 113,276
2022-06-06 EWTX MOORE JOHN R 13,934 6.0345 13,934 6.0345 84,085
2022-06-03 EWTX MOORE JOHN R 15,230 6.0537 15,230 6.0537 92,198

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EWTX / Edgewise Therapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by John R Moore as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -2,098 10,214 -17.04 13.39 -28,097 136,790
2025-08-14 2025-08-12 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,781 12,312 88.52
2025-05-07 2025-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,930 6,531 -22.81 16.45 -31,757 107,462
2025-05-07 2025-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,209 8,461 160.18
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -20,922 3,252 -86.55 27.63 -578,064 89,851
2024-09-24 2024-09-23 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 20,922 24,174 643.36 0.71 14,855 17,164
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -50,000 3,252 -93.89 28.37 -1,418,510 92,260
2024-09-24 2024-09-20 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 50,000 53,252 1,537.52 0.71 35,500 37,809
2024-05-03 2024-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,956 3,252 -37.56 18.91 -36,988 61,495
2024-05-03 2024-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 5,208
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,029 0 -100.00 20.01 -160,657
2024-02-09 2024-02-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 8,029 8,029 1.93 15,496 15,496
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,813 0 -100.00 20.01 -76,285
2024-02-09 2024-02-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,813 3,813 1.93 7,359 7,359
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,993 0 -100.00 20.00 -359,864
2024-02-09 2024-02-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 17,993 17,993 1.93 34,726 34,726
2023-12-28 2023-12-27 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -8,497 0 -100.00 10.50 -89,218
2023-05-03 2023-05-02 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,897 6,565 -22.42 8.90 -16,893 58,461
2023-05-03 2023-05-01 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,208 8,462 160.05
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -4,730 3,000 -61.19 9.76 -46,155 29,274
2022-10-05 2022-10-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,351 3,000 -43.94 10.99 -25,842 32,976
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -2,379 5,351 -30.78 10.83 -25,756 57,931
2022-09-08 2022-09-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,730 7,730 157.67 1.93 9,129 14,919
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -9,232 3,000 -75.47 9.31 -85,921 27,921
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 12,232 58.24 0.71 3,196 8,685
2022-08-05 2022-08-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,730 7,730 157.67 1.93 9,129 14,919
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -1,046 3,000 -25.85 8.54 -8,928 25,606
2022-07-07 2022-07-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 1,046 4,046 34.87 1.93 2,019 7,809
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -8,186 3,000 -73.18 8.35 -68,329 25,041
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 4,502 11,186 67.35 0.71 3,196 7,942
2022-07-07 2022-07-05 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 3,684 6,684 122.80 1.93 7,110 12,900
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -31,078 3,000 -91.20 7.29 -226,695 21,883
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,570 34,078 106.43 1.93 33,910 65,771
2022-06-21 2022-06-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,508 16,508 450.27 0.71 9,591 11,721
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -22,127 3,000 -88.06 6.62 -146,434 19,854
2022-06-21 2022-06-17 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 22,127 25,127 737.57 1.93 42,705 48,495
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -14,722 3,000 -83.07 6.17 -90,805 18,504
2022-06-21 2022-06-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 14,722 17,722 490.73 1.93 28,413 34,203
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -18,075 3,000 -85.77 6.11 -110,445 18,331
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -585 21,075 -2.70 6.11 -3,575 128,777
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 585 21,660 2.78 1.93 1,129 41,804
2022-06-15 2022-06-15 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 18,075 21,075 602.50 0.71 12,833 14,963
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -3,628 3,000 -54.74 6.02 -21,855 18,072
2022-06-15 2022-06-14 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 3,628 6,628 120.93 0.71 2,576 4,706
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -4,093 3,000 -57.70 6.01 -24,582 18,017
2022-06-15 2022-06-13 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 4,093 7,093 136.43 0.71 2,906 5,036
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,125 3,000 -70.37 6.05 -43,120 18,156
2022-06-10 2022-06-10 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,125 10,125 237.50 0.71 5,059 7,189
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -7,615 3,000 -71.74 6.49 -49,397 19,460
2022-06-10 2022-06-09 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 7,615 10,615 253.83 0.71 5,407 7,537
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -12,566 3,000 -80.73 6.63 -83,362 19,902
2022-06-10 2022-06-08 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 12,566 15,566 418.87 0.71 8,922 11,052
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -17,150 3,000 -85.11 6.60 -113,276 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 17,150 20,150 571.67 0.71 12,176 14,306
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -973 3,000 -24.49 6.60 -6,427 19,815
2022-06-07 2022-06-07 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 973 3,973 32.43 1.93 1,878 7,668
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -13,934 3,000 -82.28 6.03 -84,085 18,104
2022-06-07 2022-06-06 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 13,934 16,934 464.47 1.93 26,893 32,683
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale -15,230 3,000 -83.54 6.05 -92,198 18,161
2022-06-07 2022-06-03 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise X 15,230 18,230 507.67 1.93 29,394 35,184
2022-05-18 2022-05-16 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
S - Sale X -10,800 3,000 -78.26 7.42 -80,146 22,263
2022-05-03 2022-05-01 4 EWTX Edgewise Therapeutics, Inc.
Restricted Stock Units
A - Award 15,625 15,625
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 205,322 -2.56
2022-01-25 2022-01-21 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 12,362 77.56 0.71 3,834 8,777
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -5,400 210,722 -2.50
2021-12-30 2021-12-28 4 EWTX Edgewise Therapeutics, Inc.
Common Stock
M - Exercise 5,400 6,962 345.71 0.71 3,834 4,943
2021-08-19 2021-08-17 4 EWTX Edgewise Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 120,000 120,000
2017-04-06 2017-04-01 4/A ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -6,370 40,102 -13.71 8.94 -56,948 358,512
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -6,718 20,157 -25.00
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -4,408 42,064 -9.49 8.94 -39,408 376,052
2017-04-04 2017-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 6,718 46,472 16.90
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 131,250 131,250
2016-12-29 2016-12-27 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 21,875 21,875
2016-09-14 2016-09-12 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 12,300 12,300
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 26,875 26,875
2016-04-05 2016-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -2,505 39,754 -5.93 3.00 -7,515 119,262
2015-09-15 2015-09-11 4 NVLS Nivalis Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 7,650 7,650
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-06-16 3 NVLS Nivalis Therapeutics, Inc.
Common Stock
4,326
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 161,250 161,250
2015-04-03 2015-04-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 26,875 42,259 174.69
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
M - Exercise -22,906 22,906 -50.00
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
F - Taxes -7,542 15,364 -32.93 7.96 -60,034 122,297
2015-03-04 2015-03-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 22,906 22,906 7.96 182,332 182,332
2014-08-20 2014-08-18 4 ARRY ARRAY BIOPHARMA INC
Restricted Stock Units
A - Award 45,812 45,812
2014-04-03 2014-04-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 125,000 125,000
2013-12-03 2013-11-29 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -11,666 20 -99.83 5.79 -67,546 116
2013-11-15 2013-11-13 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -200 11,686 -1.68 5.79 -1,158 67,662
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -30,000 30,000 -50.00
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -13,884 9,375 -59.69
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -43,884 11,886 -78.69 7.03 -308,469 83,549
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 30,000 55,770 116.41 3.06 91,800 170,656
2013-08-02 2013-08-02 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 13,884 25,770 116.81 3.01 41,791 77,568
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -14,241 23,259 -37.98
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise X -12,500 12,500 -50.00
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -31,500 11,886 -72.60 7.00 -220,635 83,253
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 14,241 43,386 48.86 3.01 42,865 130,592
2013-08-02 2013-08-01 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 12,500 29,145 75.10 2.74 34,250 79,857
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -4,759 0 -100.00
2013-07-25 2013-07-25 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise 4,759 16,645 40.04 3.75 17,846 62,419
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -5,000 25,000 -16.67
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -5,000 11,886 -29.61 6.50 -32,500 77,259
2013-07-25 2013-07-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 5,000 16,886 42.07 2.74 13,700 46,268
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
M - Exercise -20,000 30,000 -40.00
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
D - Sale to Issuer X -20,000 11,886 -62.72 6.52 -130,400 77,497
2013-04-24 2013-04-23 4 ARRY ARRAY BIOPHARMA INC
Common Stock
M - Exercise X 20,000 31,886 168.27 2.74 54,800 87,368
2013-04-01 2013-03-28 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 80,000 80,000
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -2,357 0 -100.00 5.69 -13,401
2012-10-09 2012-10-08 4 ARRY ARRAY BIOPHARMA INC
Common Stock
S - Sale X -26,190 11,886 -68.78 5.69 -148,911 67,581
2012-10-05 2012-10-04 4 ARRY ARRAY BIOPHARMA INC
Common Stock
A - Award 11,886 38,076 45.38
2012-04-03 2012-03-30 4 ARRY ARRAY BIOPHARMA INC
Stock Option (Right to Buy)
A - Award 75,000 75,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)